Profiteering Laws Fail Prostate Cancer Patients

Nov. 6 (Bloomberg) -- At up to $40,000 per patient, intensity-modulated radiation therapy, or IMRT, is one of the most profitable prostate cancer treatments for urologists, while not necessarily the most effective, according to several medical studies. One in five urologists now boost their income by billing for the therapy, according to a survey by the Urology Times. Bloomberg's Kevin Thrash reports on some urologists in Monterey County, California, who are being investigated by U.S. Department of Health and Human Services for possibly putting profits ahead of patients. (Source: Bloomberg)

Breaking Down Japan's June Trade Data
23:28 - Martin Schulz, senior economist at the Fujitsu Research Institute, discusses Japan's trade data for June and what it means for the yen and the economy. He speaks to Bloomberg's Yvonne Man and Betty Liu on "Daybreak Asia." (Source: Bloomberg)
  • DNC Chair Resigns After Leaked Emails
  • Yuan Flunks Fed Haven Test
  • G-20 to Fight Weak Global Recovery